Tara Karns-Wright, PhD, MS, director of Naloxone Texas, a program of the Be Well Institute on Substance Use and Related Disorders at the University of Texas at San Antonio and its patient-care enterprise, UT Health San Antonio, and assistant professor in the Department of Psychiatry and Behavioral Sciences, was quoted in this article.